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ABSTRACT 
Establishing Novel Relationships between Genetic Variants and Gene Expression in Humans. 
(May 2013) 
 
Ishita Mandhan 
Department of Electrical Engineering 
Texas A&M University 
 
Research Advisor: Dr. James Cai 
Department of Veterinary Integrative Biosciences 
 
We observe phenotypic variations in the human population every day; however, the underlying 
genetic mechanism behind these variations is difficult to decipher. In this project I investigate the 
links between phenotypic and genetic variations in humans via three different studies. First, I 
focus on the impact of the loss-of-function (LoF) mutations on the gene expression.  To study the 
impact of LoF mutations on gene expression, messenger RNA (mRNA) sequences were aligned 
generating a map of similarities and differences in the RNA seq around the LoF mutation being 
analyzed. The patterns of RNA seq alignment were studied using the Integrative Genomics 
Viewer and compared with the list of LoF mutations. The results from the study of LoF 
mutations confirmed the presence of mutations which impact the gene expression for a particular 
disease and also reinstated the RNA-seq data obtained. Therefore, the genetic variants present 
did not necessarily cause the disease in all cases and the gene was not expressed when LoF 
mutations were present. This RNA editing mechanism protects individuals from the expression 
of the LoF mutations. Second, I focus on the expression level of mitochondrial DNA (mtDNA)-
encoded genes. FPKM (fragments per kilobase of exon per million fragments) was used in the 
study of mtDNA-encoded genes to measure the relative abundance of transcripts in the RNA seq 
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data. The study of mtDNA-encoded genes showed the presence of individual variations in the 
expression levels of the mtDNA and nuclear DNA encoded genes. I also found that the 
expression of nuclear genes is correlated to the expression of mtDNA-encoded genes.  
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CHAPTER I 
INTRODUCTION 
 
The building blocks of life, DNA, are made up of sequences of nucleotides which have both 
coding and non-coding segments, called exons and introns, respectively. In the process of DNA 
transcription, the DNA is spliced at various sites such that only the exons form an mRNA 
sequence and the non-coding segments are removed. The mRNA then undergoes the process of 
translation resulting in amino acid sequences of the protein products. Each cell produces 
thousands of different mRNA molecules that are translated depending on the requirements of the 
cell. This thesis concerns two issues in regard to establishing discrete relationships between 
genetic variants and gene expression in humans. 
 
First, I focus on the impact of the loss-of-function mutations on the gene expression. A genetic 
variant in the human genome refers to the difference in the genetic sequence of a human. These 
differences are known to occur numerous times in the human genome and are caused by 
spontaneous mutations. Variations on the molecular level refer to the differences in the 
nucleotide base pair sequences in the DNA or RNA that is sequenced and is under study. 
However, not every single variant explicitly contributes to a disease or abnormal trait being 
expressed. Sometimes combinations of variants are required to trigger changes in the body 
metabolisms which may be responsible for causing the disease or trait that is being analyzed. 
Next-generation sequencing (NGS) techniques have been developed to sequence the DNA at 
unprecedented speeds producing extremely large data sets of the human genomes for analysis. 
The technical development allows the large-scale sequencing of human genomes at the 
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population level, such as the 1000 Genomes Project (The_1000_Genomes_Project_Consortium 
2010), became possible. In the meantime, this allows genome-wide association studies (GWAS) 
to compare thousands of people who have a particular disease to those who do not and try to find 
patterns in their genetic sequence which occur more frequently in the affected individuals.  
 
Recently large-scale genomic data sets have been used to locate the loss-of-function mutations in 
multiple healthy individuals (MacArthur, Balasubramanian et al. 2012). Such variants have been 
regarded as rare and having a high probability of being deleterious, on the basis of their well-
established causal roles in severe Mendelian diseases such as cystic fibrosis and Duchenne 
muscular dystrophy. The loss-of-function mutations, therefore, are of considerable scientific and 
clinical interest. In the systematic survey of the loss-of-function variants in the human genome 
by (MacArthur, Balasubramanian et al. 2012), an unexpectedly high number of genes, which 
have been rendered non-functional by loss-of-function mutations in human protein-coding genes, 
were found. The results show that human genomes on average contain about 100 genes which 
are non-functional and about 20 genes which carry inactivating mutations in both gene copies. 
This suggests that humans are able to tolerate such many loss-of-function mutations. However, 
the underlying mechanism of this tolerance is not completely known.  
 
Second, I focus on the expression level of mitochondrial DNA (mtDNA)-encoded genes. 
Eukaryotic cells contain a small chromosome in the cell organelle called the mitochondrion, 
commonly called the cellular power plant. Each cell contains several mitochondria with its own 
mitochondrial DNA (mtDNA). Mutations in the mtDNA are common as the mtDNA is more 
susceptible to oxidative damage. Causing the most damage to cells in tissues with high energy 
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demands, mitochondrial defects are associated with a number of conditions and diseases, 
including ageing, cardiovascular disease, diabetes, and cancer. (Andreu, Arbos et al. 1998, 
Karamanlidis, Bautista-Hernandez et al. 2011, Sondheimer, Glatz et al. 2011)  
 
Very little has been studied about the mtDNA and its transcription in comparison to nuclear 
DNA (nDNA). None of the large scale RNA-seq studied has focused on the transcription process 
in mtDNA. The lack of knowledge makes it harder to understand mitochondrial diseases and 
how they can be controlled and prevented. We study the mitochondrial gene expression in 
mRNA sequencing results which contain many mitochondrial transcripts in European 
populations. We hypothesize that the expression levels of mitochondrial DNA encoded genes are 
about as variable as those of nuclear DNA encoded genes and do not vary as much between 
individuals. The expression of mtDNA and nDNA encoded genes are compared and the patterns 
are then studied. 
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CHAPTER II 
METHODS 
 
Impact of loss-of-function mutations on gene expression 
The dataset for this project was obtained from the 1000 genomes project 
(The_1000_Genomes_Project_Consortium 2010) and the sequences were extracted for all 
individuals having gene expression data. The genotype data of phase 1 of the 1000 genomes 
project was downloaded from the project official website at http://www.1000genomes.org. The 
nucleotide sequences were then converted to MATLAB matrices using integer equivalents to 
ATGC i.e., 1 corresponds to A, 2 corresponds to C, 3 corresponds to G and 4 corresponds to T.  
 
A list of loss-of-function mutations was obtained from the supplementary data of the study of 
(MacArthur, Balasubramanian et al. 2012) (see Figure 1 for an example). This list contained the 
genomic locations, reference alleles, alternative alleles, and function effects of loss-of-function 
variants from existing literature. The indel mutations were filtered out and the main focus was on 
the single nucleotide variants (SNVs). Figure 1 shows a table of examples of loss-of-function 
SNVs extracted from the supplementary table of (MacArthur, Balasubramanian et al. 2012). 
These loss-of-function mutations were found in 1000 Genomes samples and are known to be 
associated with human complex diseases. 
9 
 
 
Figure 1. Examples of loss-of-function SNVs. Data source:(MacArthur, Balasubramanian et al. 
2012). 
 
Further analysis of the RNA-seq was carried forward using the various toolboxes developed by 
Dr. Cai (Cai, Smith et al. 2005, Cai, Smith et al. 2006, Cai 2008). The mRNA sequences were 
aligned for a particular range of base pairs in a chromosome obtained from the loss-of-function 
mutation data generating a map of similarities and differences in the RNA seq around the loss-
of-function mutation being analyzed. Original RNA-seq reads produced by Montgomery, 
Sammeth et al. (2010) and were downloaded from NCBI Gene Expression Omnibus (GEO) 
under accession numbers GSE19480 and GSE25030 for CEU samples (Montgomery, Sammeth 
et al. 2010).  
 
One explanation for the existence of loss-of-function mutations in healthy individuals might be 
RNA editing (Gott and Emeson 2000), a highly regulated molecular process in which the RNA 
sequence is chemically and enzymatically altered. One way to identify RNA editing events is 
through rigorous sequence data analyses to reliably identify RNA-DNA differences 
(RDDs)(Kleinman and Majewski 2012, Lin, Piskol et al. 2012, Pickrell, Gilad et al. 2012). We 
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systematically examined the RDDs at the site of known loss-of-function mutations in multiple 
1000 genomes samples. We used a series of Matlab-based software toolboxes (Cai, Smith et al. 
2005, Cai, Smith et al. 2006, Cai 2008) and other existing software tools, such as samtools (Li, 
Handsaker et al. 2009) and integrative genomics viewer (Robinson, Thorvaldsdottir et al. 2011), 
to conduct the analyses and produce visual results of the RNA-seq read alignments of different 
individuals at the same SNP in a particular chromosome. 
 
Expression level of mtDNA encoded genes 
RNA-seq data produced by Montgomery, Sammeth et al. (2010) were downloaded from NCBI 
Gene Expression Omnibus (GEO) under accession numbers GSE19480 and GSE25030 for CEU 
samples. Mitochondria and mitoplast RNAseq data produced by Mercer, et al. were downloaded 
from GEO under accession number GSE30772. For each data set, the Sequence Read Archives 
(SRA) files were downloaded and population specific reference genomes were obtained. The 
human gene annotation—Gencode v12 was downloaded from the website of the GENCODE 
project (http://www.gencodegenes.org/). Because large amount of RNA-seq reads were mapped 
onto mitochondrial genome, it was important to have accurate mitochondrial reference genomes.  
 
FPKM (fragments per kilobase of exon per million fragments) was used in this study to measure 
the relative abundance of transcripts. To estimate FPKM, short reads were mapped to 
corresponding population-specific reference genome. The representative housekeeping genes,  
AATF, ADAR, BSG, E2F4, MGAT1, NDUFA7, PGD, RBM8A, SOD1, TACC1, TALDO1, 
UBE2D2, and YWHAB, were randomly selected from the list of housekeeping genes obtained 
from the study of Eisenberg and Levanon.  
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The weighted gene correlation network analysis (WGCNA) is a data reduction method that 
groups genes into modules which are clusters of densely interconnected genes in an unsupervised 
manner based on self-organizing properties of complex systems. R package WGCNA was used 
to create nuclear gene co-expression modules and estimate the correlation between modules and 
mitochondrial expression. Modules were identified among genes whose expression is highly 
correlated in CEU populations. We used the average expression level of mitochondrial genes in 
each sample as the trait. This allowed us to identify the modules highly correlated with 
mitochondrial gene expression. We then examined gene functions for the top three significant 
modules with genes positively correlated with mitochondrial genes and the top three significant 
modules with negatively correlated genes. For each module, we computed enrichment scores for 
the GO biological process and molecular function terms. The Gene Ontology (GO) analysis was 
conducted using DAVID. 
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CHAPTER III 
RESULTS 
 
The results intensified the idea of an RNA editing mechanism that functions at the transcriptional 
level to eliminate the deleterious effects caused by the loss-of-function mutations. Transcription 
is the process of formation of a RNA strand complementary to the DNA copy. The loss-of-
function mutations that can be found at the DNA level have a parallel gene code of the mRNA 
which shows similar patterns. If the transcription of DNA sequence into mRNA occurs without 
any editing, we should be able to identify the same nucleotides of loss-of-function mutations in 
the mRNA transcripts. However this is not the case in the data that was analyzed in the study. 
The results of several different sites of mutation showed the possibility of transcription occurring 
with an RNA editing mechanism. 
 
Figure 2 shows aligned mRNA reads around the site of the loss of function mutation for four 
individuals with ids ERR009096, ERR009097, ERR009099, and ERR009102 respectively. 
Thymine at the 31124849 base pair position on chromosome 6 of the CCHCR1 gene indicates 
the presence of mutation unless cytosine is present predominantly in turn covering up for the 
very little/no thymine. The CCHCR1 gene has been linked to the psoriasis phenotype in humans 
(Gandhi, Buttar et al. 2011). Due to the function of the compensatory mechanism for eliminating 
the Loss-of-function mutations, the mutational profile of mRNA transcripts at the site of the 
Loss-of-function mutation was different from that of the genomic DNA.  
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Figure 2. Nucleotide sequences of four individuls at the 31124849 base pair position on 
chromosome 6 of the CCHCR1 gene. 
 
Aligned mRNA reads around the site of the loss of function mutation, i.e., at the 32411035 base 
pair position, for four individuals with ids ERR009096, ERR009097, ERR009099, and 
ERR009102 respectively can be seen in figure 3. This base pair position on chromosome 6 of the 
human HLA-DRA gene is essential for immune responsiveness to foreign antigens(Matsushima, 
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Itoh-Lindstrom et al. 1993). The absence of any nucleotide at the site of mutation denotes the 
presence of a nucleotide base as expected based off of the genomic DNA. The presence of 
cytosine in individuals 2 and 3 implies that these individuals show the mutation at the loss-of-
function mutation sites but remain phenotypically unaffected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Nucleotide sequences of four individuls at the 32411035 base pair position on 
chromosome 6 of the HLA-DRA gene. 
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The gene expression level for 60 CEU individuals was compared for both mitochondrial and 
nuclear DNA encoded genes. The expression levels for mitochondrial DNA encoded genes 
showed greater variability than the nuclear DNA encoded genes. This marked difference can be 
seen by observing the closer quartile ranges for nuclear DNA encoded genes on graph b 
compared to the more distant quartile ranges for mitochondrial DNA encoded genes on graph a. 
Also, the between-individual variance in expression level in mt-DNA encoded genes is larger 
than nuclear DNA encoded genes. The expression of all 13 of the mt-DNA encoded 
housekeeping genes examined is positively correlated to each other. This could be attributed to 
the fact that most of them encode for parts of the electron transport chain and are therefore 
closely related. 
 
 
 
 
16 
 
 
 
 
Figure 4. Between-individual variation of mitochondrial gene expression and normalized gene 
expression levels in 60 CEU individuals for mt-DNA encoded genes (a) and nuclear DNA 
encoded genes (b).  
17 
 
 
 
 
Figure 5. Pairwise correlations of expression level between mt-DNA encoded genes (a) and 
nuclear DNA encoded genes (b). 
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CHAPTER IV 
DISCUSSION 
 
Inactivation of a gene can have several different phenotypic effects, like inactivation of the gene 
without clinical impact(MacArthur, Balasubramanian et al. 2012). One possible reason behind 
such loss-of-function tolerant genes is the presence of an RNA editing mechanism that enables 
the site of mutation to be overlooked during transcirption inturn supressing the phenotypic 
expression of the mutation. Our results provide the direct evidence in humans that RNA-editing 
may play a role in attenuating the detrimental impact on gene transcription caused by the loss of 
function mutations. Nevertheless, there are several severe recessive genes which are caused by 
mutations. Further sequencing studies that analyze the impact of these mutations can be used to 
improvise on clinical treatments.  
 
Despite tehcnical advancements like the spindle transfer technique(Tachibana, Amato et al. 
2013), our understanding of the generic regulation of trasncription of mtDNA encoded genes is 
still fairly low. Some diseases that are caused by alterations in the mitochondrial DNA include 
Alzheimer’s disease (Chandrasekaran, Giordano et al. 1994, Chandrasekaran, Hatanpaa et al. 
1997) and nephrotic syndrome (Holthofer, Kretzler et al. 1999). It is essential to learn more about 
mitchondrial diseases to prevent and treat them. Our lack of knowledge of the trasncriptional 
process in the mitochondrial DNA should not be in the way of how these set of diseases are dealt 
with.  
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We studied the expression levels of 13 mitochondrial housekeeping genes and compared them 
with nuclear DNA encoded genes. We also compared the expression levels of mitochondrial 
genes between 60 individuals in the European population being analyzed, which has been 
neglected by a large majority of previous studies. Using  existing data sets, we revealed the 
population-level expression variability of mtDNA-encoded genes in European populations. Next 
we tried to understand the correlation in expression levels between mitochondrial and nuclear 
genes. There is a clear need to integrate information from both mitochondrial and nuclear 
genetic systems by describing genetic and expression profiles of both genomes(Pesole, Allen et 
al. 2012). We found that the expressions of many nuclear genes are either positively or 
negatively associated with the expression of at least one of the mtDNA-encoded genes in CEU 
populations. 
 
Mitochondria are not only important for the energetic status of the cell, but also the fatal 
organelles deciding about cellular life and death - apoptosis and  mitochondria relationship is 
known in lower eukaryotic organisms like yeast(Eisenberg, Buttner et al. 2007). Previous 
comparative analysis across species also suggested that many pathways connected to the 
respiratory chain are still undiscovered(Vafai and Mootha 2012). Thus, the co-expression we 
detected may have helped identify these new pathways. 
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CHAPTER V 
CONCLUSIONS 
 
The analysis of loss-of-function variants in 43 healthy individuals of the CEU population showed 
that most individuals do contain several mutations in heterozygous state which do not necessarily 
impact us. These variants are likely to be in non-essential genes and so they do not affect the 
normal functioning and do not create any sort of phenotypic variations. In the case when 
homozygous state of a LoF mutation indeed happens, RNA-editing is found to play a role to 
attenuate the negative impact of the mutations to normal gene transcription. 
 
By studying the expression levels of mitochondrial and DNA encoded genes in 60 CEU 
individuals we have realized the presence of a significant amount of variation in the expression 
levels across individuals in mtDNA encoded genes. We also learned that there was a similar 
trend of more varied expression levels for mitochondrial genes when compared to nuclear genes 
which showed lesser variability. One possible explanation for the variability is that 
mitochondrial DNA encoded genes are mainly responsible for housekeeping genes and so vary 
because of the different body metabolisms that need to be regulated at all steps. This could also 
explain the overall general trend of gene expression of the 60 individuals since we all follow 
basic housekeeping processes. Our analysis establishes the null expectation of mtDNA gene 
expression variability in human populations. Future studies of the genetic basis of gene 
expression of mitochondrial DNA encoded genes will be able to explain the mechanisms behind 
such variability. 
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